A surgeon's obligations when performing new procedures  by Jones, James W. & McCullough, Laurence B.
SURGICAL ETHICS CHALLENGES
A surgeon’s obligations when performing new
procedures
James W. Jones, MD, PhD,a and Laurence B. McCullough, PhDb
409
quacy, however, and this is a process that should receive
more professional scrutiny than it does. Choice C, con-
cerning experienced operative assistance, is related to item
A in the sense that most manufacturers of surgical high
technology will send an experienced surgeon to assist, and
continue training, in the operating room during a sur-
geon’s first few procedures with a new method. There is
no evidence that our surgeon rejected available help.
Choice D, respecting credentialing and IRB autho-
rizations, approaches a more difficult realm. With no spe-
cific criteria for the conduct of robotic surgery (or likely
many other new procedures) included in the medical cen-
ter’s credentialing process, the usual “full privilege” desig-
nation permits the procedure. Centers using this blanket
privileging terminology are skirting their oversight
responsibility. There is a potential ethical breach here, but
it resides with the institution, not the surgeon.
Because this robotic procedure is not part of a struc-
tured research protocol, it will not normally be subject to
IRB oversight, but a question arises about whether our
case does in fact constitute experimentation. Innovation is
sanctioned by the profession and society at large, which
permits surgeons to make choices based upon clinical
judgment. These choices include everyday decisions about
prophylactic antibiotics, conduit selection, and which
arteries to treat. Innovation becomes experimentation
when the outcome cannot be reliably predicted. This is the
case when a surgeon uses a complex new technology
requiring new surgical skills and knowledge or when a sur-
geon attempts a procedure he has never done before.
The distinction changes the surgeon’s obligations
toward his patient regarding informed consent. Valid con-
cerns that new surgical procedures are inadequately mon-
itored have been articulated for many years.2
Innovations may be required unexpectedly to meet
intraoperative exigencies, but patients must be informed if
they are to become participants in experimentation. Our
surgeon has not done enough robotic-assisted aneurys-
mectomies to develop a statistical outcome profile. His
results can therefore not be reliably predicted, the hall-
mark of experimentation. He should specifically disclose
his previous results to each patient whom he proposes to
operate upon with this method until he can be confident
of expectations. The ethical surgeon will not oversell the
potential benefits of a new procedure while omitting what
A junior member of the vascular surgery faculty has
done two robotic abdominal aneurysmectomies.
Although he attended a standard 2-day training
course conducted by the instrument manufacturer,
performed several similar procedures in the animal
laboratory, and read all the recent pertinent literature,
technical errors resulted in significant morbidity in his
first two patients. He proposes to use the technique
once again on a hospitalized patient. His troubled
chairman has called you for an opinion on whether an
ethical question has now arisen. There are no specific
credentialling standards for robotic surgery at this
institution. Where might we most expect to see an eth-
ical problem in the surgeon’s management of the new
case?
A. In the level of training for robotic surgery.
B. In the selection of patients.
C. In the level of assistance sought from more experi-
enced surgeons.
D. In compliance with credentialing and Institutional
Review Board (IRB) requirements.
E. In disclosure to the prospective patient.
The most likely ethical oversight is E, in disclosure of
the surgeon’s experience and outcomes with the robotic
procedure. The least relevant answer is B; there is no evi-
dence that patients have been improperly diagnosed or
chosen only to expand the surgeon’s case series with the
new procedure.
Choice A implies skepticism about the adequacy of the
brief manufacturer-provided courses typically used to
introduce surgeons to new technology. Surgeons and
trainers alike usually find that these concentrated sessions
provide sufficient hands-on experience with novel instru-
mentation. This training method has been generally suc-
cessful and is widely accepted by the profession as effective
and ethical. Group acceptance does not always mean ade-
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the patient most needs for informed consent—knowledge
that the surgeon has very limited experience in the proce-
dure and a high morbidity rate.
The literature confirms that fully experienced surgeons
have a learning curve when even slightly different skill sets
are needed, increasing the likelihood that early patients
will not realize the same quality of results as those treated
after more experience has been gained. Until a favorable
surgical outcome can be realistically anticipated, the learn-
ing period is effectively experimental. For it to be war-
ranted, there must be the prospect of knowledge to be
gained and adequate assurance that standards of care are
maintained.
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